Capros®, backed by 8 clinical studies and one mechanism of action study, is an excellent product for Heart Health. In addition, it is a super antioxidant with an ORAC value of 47,000 µmoles TE/gram. Capros® has a new patent issued on endothelial function enhancement, increased production of NO, decreased LDL and increased HDL. Two other patents cover platelet aggregation inhibition properties and pro-oxidation-free anti-oxidant properties. Peer reviewed publications pending include “Supplementation of a Standardized Extract from Phyllanthus emblica Improves Cardiovascular Risk Factors and Platelet Aggregation in Overweight Adults” and “Protective Effects of Phyllanthus emblica derived Capros® on Myocardial Ischemia-Reperfusion Injury via Activation of the PI3-Kinase / Glycogen Synthase Kinase-3β/ β-Catenin Cardio-Protective Pathway”.